Chronic diarrhea often gets labeled as IBS and left there. For a meaningful share of people carrying that label, the real problem is a bile acid imbalance that nobody has tested for. This biomarker is the simplest blood test to look for it.
7AC4 (7α-hydroxy-4-cholesten-3-one) is a cholesterol intermediate your liver releases when it ramps up bile acid production. High levels usually mean your liver is working overtime to replace bile acids that are being lost in your stool. That pattern shows up in bile acid diarrhea, ileal Crohn's disease, and changes after bowel surgery.
Your liver makes bile acids from cholesterol using an enzyme called CYP7A1, which you can think of as the starting switch for the whole pathway. 7AC4 is the product of that first step, so measuring it in blood tells you how hard CYP7A1 is working. This is why 7AC4 is called a surrogate marker of bile acid synthesis: it rises and falls with the rate at which your liver turns cholesterol into bile acids.
Bile acids are recycled. Your liver secretes them into the gut to help digest fat, most are reabsorbed in the last part of the small intestine (the ileum), and the liver reuses them. When that recycling breaks down, bile acids get dumped into the colon, and the liver responds by making more. More synthesis means more 7AC4 in your blood.
Bile acid diarrhea is a condition where too many bile acids reach the colon and trigger watery, urgent stools. It is commonly mistaken for IBS-D (the diarrhea-predominant type of irritable bowel syndrome). 7AC4 is the most practical blood test to flag it, because synthesis ramps up to compensate for the loss.
In a study of 101 adults with IBS-D or functional diarrhea, a fasting serum 7AC4 level at or above 52.5 ng/mL (the 95th percentile from 184 healthy adults) was a positive result for bile acid diarrhea. Compared against a 48-hour stool test, 7AC4 had a specificity of about 83%, meaning it correctly cleared roughly 83 out of 100 people who did not have bile acid diarrhea. A normal result is a strong reason to rule bile acid diarrhea out.
What this means for you: if you have chronic unexplained diarrhea and your 7AC4 is clearly elevated, there is a specific treatment (bile acid binders) that often works quickly. If your 7AC4 is normal, bile acid diarrhea is unlikely and the workup should focus elsewhere.
The ileum is where bile acids are reabsorbed. When disease or surgery damages it, reabsorption fails and synthesis spikes. In adults with distal ileal Crohn's disease or ileal resection, 7AC4 is markedly higher than in healthy controls. In an IBD outpatient cohort, a level above 234 ng/mL predicted response to cholestyramine, especially after ileocecal resection.
A separate study in 84 adults with Crohn's disease found that a 7AC4 cutoff of 48.3 ng/mL or greater identified those whose diarrhea was coming from bile acid malabsorption rather than active inflammation. This matters because the treatments are completely different: inflammation needs immunosuppression, bile acid malabsorption needs a bile acid binder.
In children with Crohn's disease, elevated 7AC4 often appeared even when standard inflammation markers (CRP, fecal calprotectin) and disease activity scores looked fine. This pattern flagged a subgroup whose persistent diarrhea was driven by bile acid loss, not flaring disease, and who responded to bile acid binding therapy.
7AC4 is not only a gut test. Because bile acid synthesis is how your body disposes of cholesterol, this biomarker connects to broader metabolic health. In adults with non-alcoholic fatty liver disease, serum 7AC4 tends to run higher, reflecting a compensatory increase in synthesis alongside greater fecal bile acid loss.
In overweight adults with hyperinsulinemia, a six-week high-dairy diet (four or more servings per day) raised 7AC4 and strengthened its links with proteins involved in HDL remodeling and reverse cholesterol transport, the system that returns cholesterol from tissues to the liver. In obese women, roughly four months of exercise plus calorie restriction raised fasting 7AC4 by about 24 to 55% and lowered total circulating bile acids by about 30%, consistent with more efficient bile acid turnover.
Higher 7AC4 can be good news or bad news depending on the context. In bile acid diarrhea or ileal Crohn's, a high level reflects a pathological compensation for bile acid loss. After exercise and weight loss, a higher fasting 7AC4 reflects a healthier, more responsive feedback system. 7AC4 is not a simple "higher equals worse" marker. It is a synthesis-rate indicator, and the interpretation depends on why synthesis is elevated. That is why this biomarker is best read alongside your symptoms and a companion bile acid test, not in isolation.
7AC4 has wide natural variation between people, and published cutpoints come from small populations using similar but not identical assays. The ranges below come from a study of 184 healthy adults measured by liquid chromatography tandem mass spectrometry. They are orientation, not a universal target. Your lab may report in slightly different units or use a different cutoff.
| Tier | Range (ng/mL) | What It Suggests |
|---|---|---|
| Normal | Below 52.5 | Bile acid synthesis in a typical range; bile acid diarrhea unlikely |
| Elevated | 52.5 or higher | Increased bile acid synthesis; bile acid diarrhea or ileal bile acid loss warrants investigation |
| High in IBD context | 234 or higher | In Crohn's disease or after ileocecal resection, predicts response to cholestyramine in one outpatient cohort |
Source: Camilleri et al. 2009 (healthy reference range and IBS-D cutoff); Friedli et al. 2019 (IBD cutoff). A separate European study proposed a threshold above 48.9 ng/mL for bile acid malabsorption in microscopic colitis and IBD. Compare your results within the same lab over time for the most meaningful trend.
Bile acid synthesis follows a clear daily rhythm. In healthy volunteers, serum 7AC4 shows two daytime peaks, around 1 pm and 9 pm, climbing to roughly two to four times baseline before falling overnight. This rhythm persists even after gallbladder removal. A single reading caught at the wrong time of day can over- or underestimate your true average.
Reproducibility studies in stable IBS-D show that about 78% of 7AC4 results stay in the same category (normal or abnormal) on repeat testing, meaning roughly one in five people can cross the threshold on a second draw. A practical plan: get a fasting baseline in the morning, retest in 3 to 6 months if you start a dietary change or medication that could affect the result, and track at least annually if bile acid metabolism is part of your ongoing picture. Multiple fasting morning readings beat one result every time.
An isolated high 7AC4 is a lead, not a verdict. The next step depends on what else is going on. If you have chronic diarrhea, the most useful companion test is FGF19, a hormone made in the small intestine that normally signals the liver to slow bile acid synthesis. In bile acid diarrhea FGF19 tends to run low while 7AC4 runs high. An even more direct confirmation is a 48-hour stool bile acid collection or, where available, a SeHCAT scan.
If you have known Crohn's disease, ileal resection, or chronic diarrhea with a high 7AC4, a gastroenterologist can decide whether a trial of a bile acid binder (such as cholestyramine) is appropriate. If you have no GI symptoms but your 7AC4 is elevated alongside a pattern of metabolic liver findings, a liver-focused workup including liver enzymes, imaging, and bile acid profiling is the better path. A single out-of-range 7AC4 without context is a reason to retest and contextualize, not to panic.
A few situations can shift 7AC4 without telling you anything useful about your underlying biology. Read your result with these in mind:
Evidence-backed interventions that affect your 7AC4 Bile Acid Synthesis level
7AC4 Bile Acid Synthesis is best interpreted alongside these tests.